Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Medicenna Therapeutics Corp. (T.MDN) had Stock-Based Compensation of 0.80M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
-3.05M |
|
-- |
|
-- |
|
-- |
|
-4.05M |
|
-- |
|
-3.05M |
|
-3.05M |
|
-3.05M |
|
-3.05M |
|
-3.05M |
|
-3.05M |
|
-4.05M |
|
-4.04M |
|
76.84M |
|
76.84M |
|
-0.04 |
|
-0.04 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
24.13M |
|
-- |
|
-- |
|
-- |
|
9.44M |
|
14.70M |
|
14.66M |
|
14.70M |
|
77.04M |
|
| Cash Flow Statement Financials | |
-5.82M |
|
-0.02M |
|
15.83M |
|
12.45M |
|
22.30M |
|
9.85M |
|
|
Stock-Based Compensation |
0.80M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.40 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.77% |
|
-20.82% |
|
-12.65% |
|
-20.62% |
|
0.26 |
|
-0.08 |
|
-0.08 |
|